Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial (2014)
- Authors:
- Shiffman, Mitchell L.
- Cheinquer, Hugo
- Berg, Christoph P.
- Berg, Thomas
- Figueiredo-Mendes, Claudio de
- Dore, Gregory J.
- Ferraz, Maria Lucia
- Mendes-Correa, Maria Cassia
- Lima, Maria Patelli
- Parise, Edison R.
- Rios, Alma Minerva Perez
- Reuter, Tania
- Sanyal, Arun J.
- Shafran, Stephen D.
- Hohmann, Marc
- Tatsch, Fernando
- Bakalos, George
- Zeuzem, Stefan
- Autor USP: CORRÊA, MARIA CASSIA JACINTHO MENDES - FM
- Unidade: FM
- DOI: 10.1007/s12072-014-9555-3
- Subjects: GENÓTIPOS; HEPATITE CRÔNICA; INTERFERONS; VÍRUS DA HEPATITE C
- Language: Inglês
- Imprenta:
- Source:
- Título: Hepatology International
- ISSN: 1936-0533
- Volume/Número/Paginação/Ano: v. 8, n. 4, p. 517-526, 2014
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão submetida (Pré-print)
-
Status: Artigo possui versão em acesso aberto em repositório (Green Open Access) -
ABNT
SHIFFMAN, Mitchell L. et al. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, v. 8, n. 4, p. 517-526, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12072-014-9555-3. Acesso em: 10 mar. 2026. -
APA
Shiffman, M. L., Cheinquer, H., Berg, C. P., Berg, T., Figueiredo-Mendes, C. de, Dore, G. J., et al. (2014). Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. Hepatology International, 8( 4), 517-526. doi:10.1007/s12072-014-9555-3 -
NLM
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1007/s12072-014-9555-3 -
Vancouver
Shiffman ML, Cheinquer H, Berg CP, Berg T, Figueiredo-Mendes C de, Dore GJ, Ferraz ML, Mendes-Correa MC, Lima MP, Parise ER, Rios AMP, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial [Internet]. Hepatology International. 2014 ; 8( 4): 517-526.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1007/s12072-014-9555-3 - Noninvasive models for predicting liver fibrosis in individuals with hepatitis D virus/hepatitis B virus coinfection in the brazilian amazon region
- Evaluation of the utilization of filmArray meningitis/encephalitis in children with suspected central nervous system infection a retrospective case series
- How are HCV-infected patients being identified in Brazil: a multicenter study
- Hepatitis B: prevalence and occult infection in HIV-infected patients
- Hepatitis C disease burden and strategies for elimination by 2030 in Brazil.: a mathematical modeling approach
- Disease burden of chronic hepatitis C in Brazil
- Análise exploratória espacial de casos de HBV no Brasil entre 2005 e 2017
- Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
- Viral hepatitis and HIV: Update and management
- Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
